Physiological Ventricular Pacing Vs Managed Ventricular Pacing for Persistent AF Prevention in Prolonged AV Interval (PhysioVP-AF)
Physiological Ventricular Pacing Versus Managed Ventricular Pacing for Persistent Atrial Fibrillation Prevention in Patients With Prolonged Atrioventricular Interval: a Multicenter RCT
Sponsor: Quovadis Associazione
A NA clinical study on Atrioventricular; Block, Second Degree (Types I and II) and Sinus Node Disease, this trial is actively recruiting participants. The trial is conducted by Quovadis Associazione and has accumulated 7 data snapshots since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Jun 2025 — Present [monthly]
Recruiting NA
-
Dec 2024 — Jun 2025 [monthly]
Recruiting NA
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Oct 2023 — Jul 2024 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Sep 2022 — Oct 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Quovadis Associazione
For direct contact, visit the study record on ClinicalTrials.gov .